BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats. Drug Metab Dispos 2015;43:958-68. [DOI: 10.1124/dmd.115.063370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Heusinkveld HJ, Wackers PF, Schoonen WG, van der Ven L, Pennings JL, Luijten M. Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment. Food and Chemical Toxicology 2018;121:115-23. [DOI: 10.1016/j.fct.2018.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Takemura A, Gong S, Sekine S, Ito K. Inhibition of biliary network reconstruction by benzbromarone delays recovery from pre-existing liver injury. Toxicology 2019;423:32-41. [DOI: 10.1016/j.tox.2019.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Li ZQ, Jiang LL, Zhao DS, Zhou J, Wang LL, Wu ZT, Zheng X, Shi ZQ, Li P, Li HJ. The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity. Front Pharmacol 2018;9:1033. [PMID: 30283337 DOI: 10.3389/fphar.2018.01033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Sasaki E, Iida A, Oda S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors. Exp Toxicol Pathol 2016;68:27-38. [PMID: 26391595 DOI: 10.1016/j.etp.2015.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Cao Y, Liu M, Wu S, Xu J, Wang W, Qi X, Ren J, Sun J, Chen J, Gong L. Kupffer cells play a crucial role in monocrotaline-induced liver injury by producing TNF-α. Toxicology 2022. [DOI: 10.1016/j.tox.2022.153101] [Reference Citation Analysis]
6 Jiang LL, Jiang Y, Zhao DS, Fan YX, Yu Q, Li P, Li HJ. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury. Chem Res Toxicol 2018;31:1052-60. [PMID: 30203651 DOI: 10.1021/acs.chemrestox.8b00117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
7 Jiang X, Zhou Q, Du B, Li S, Huang Y, Chi Z, Lee WM, Yu M, Zheng J. Noninvasive monitoring of hepatic glutathione depletion through fluorescence imaging and blood testing. Sci Adv 2021;7:eabd9847. [PMID: 33608272 DOI: 10.1126/sciadv.abd9847] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Elmowafy M, Shalaby K, Badran MM, Ali HM, Abdel-bakky MS, Ibrahim HM. Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation. International Journal of Pharmaceutics 2018;550:359-71. [DOI: 10.1016/j.ijpharm.2018.08.062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
9 Jia R, Oda S, Tsuneyama K, Urano Y, Yokoi T. Establishment of a mouse model of troglitazone-induced liver injury and analysis of its hepatotoxic mechanism. J Appl Toxicol 2019;39:1541-56. [PMID: 31294483 DOI: 10.1002/jat.3838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Segovia-zafra A, Di Zeo-sánchez DE, López-gómez C, Pérez-valdés Z, García-fuentes E, Andrade RJ, Lucena MI, Villanueva-paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 2021;11:3685-726. [DOI: 10.1016/j.apsb.2021.11.013] [Reference Citation Analysis]
11 Osuntokun OS, Olayiwola G, Atere TG, Adedokun KI, Oladokun OO. Graded doses of grape seed methanol extract attenuated hepato-toxicity following chronic carbamazepine treatment in male Wistar rats. Toxicol Rep 2020;7:1592-6. [PMID: 33304829 DOI: 10.1016/j.toxrep.2020.11.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yoshida M, Cho N, Akita H, Kobayashi K. Association of a reactive intermediate derived from 1',6-dihydroxy metabolite with benzbromarone-induced hepatotoxicity. J Biochem Mol Toxicol. 2017;31. [PMID: 28598529 DOI: 10.1002/jbt.21946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Aukema KG, Escalante DE, Maltby MM, Bera AK, Aksan A, Wackett LP. In Silico Identification of Bioremediation Potential: Carbamazepine and Other Recalcitrant Personal Care Products. Environ Sci Technol 2017;51:880-8. [DOI: 10.1021/acs.est.6b04345] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
14 Akai S, Oda S, Yokoi T. Strain and interindividual differences in lamotrigine-induced liver injury in mice. J Appl Toxicol 2019;39:451-60. [PMID: 30325050 DOI: 10.1002/jat.3736] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Erdem Guzel E, Kaya Tektemur N, Tektemur A, Etem Önalan E. Carbamazepine-induced renal toxicity may be associated with oxidative stress and apoptosis in male rat. Drug Chem Toxicol 2021;:1-8. [PMID: 34879783 DOI: 10.1080/01480545.2021.2014859] [Reference Citation Analysis]
16 Zhang W, Guo J, Wang D, Ren S, Hua H, Morikawa T, Pan Y, Liu X. Effect of CYP3A inducer/inhibitor on pharmacokinetics of five alkaloids in Evodiae Fructus. Chemico-Biological Interactions 2020;327:109146. [DOI: 10.1016/j.cbi.2020.109146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Matsubara A, Oda S, Jia R, Yokoi T. Acute kidney injury model established by systemic glutathione depletion in mice. J Appl Toxicol 2019;39:919-30. [DOI: 10.1002/jat.3780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Oba KI, Shimada H, Hashimoto R, Kawase A, Nakanishi T, Iwaki M. Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury. Endocr Regul 2022;56:22-30. [PMID: 35180822 DOI: 10.2478/enr-2022-0003] [Reference Citation Analysis]
19 Asai Y, Sakakibara Y, Nadai M, Katoh M. Effect of carbamazepine on expression of UDP-glucuronosyltransferase 1A6 and 1A7 in rat brain. Drug Metabolism and Pharmacokinetics 2017;32:286-92. [DOI: 10.1016/j.dmpk.2017.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Ikeyama Y, Sato T, Takemura A, Sekine S, Ito K. Hypoxia/reoxygenation exacerbates drug-induced cytotoxicity by opening mitochondrial permeability transition pore: Possible application for toxicity screening. Toxicol In Vitro 2020;67:104889. [PMID: 32417306 DOI: 10.1016/j.tiv.2020.104889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wang J, Bwayi M, Gee RRF, Chen T. PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches. Expert Opin Drug Metab Toxicol 2020;16:711-22. [PMID: 32500752 DOI: 10.1080/17425255.2020.1779701] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Jiang W, Xia T, Yun Y, Li M, Zhang F, Gao S, Chen W. UHPLC-MS/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients. Journal of Chromatography B 2019;1108:17-24. [DOI: 10.1016/j.jchromb.2018.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]